Immunic Inc Stock Forecast, Predictions & Price Target

Analyst price target for IMUX

Based on 2 analysts offering 12 month price targets for Immunic Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell IMUX stock?

Based on 2 analysts offering ratings for Immunic Inc.
Strong Buy
0 analysts 0%
1 analysts 50%
1 analysts 50%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IMUX stock forecasts and price targets.

IMUX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Bottom 16%
SVB Leerink
Top 16%

1 of 1

IMUX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ADAG$1.51$5.00+231.13%Strong Buy
ORTX$5.23$15.00+187.08%Strong Buy
LYRA$2.03$20.00+885.22%Strong Buy

Immunic Stock Forecast FAQ

Is Immunic Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: IMUX) stock is to Buy IMUX stock.

Out of 2 analysts, 0 (0%) are recommending IMUX as a Strong Buy, 1 (50%) are recommending IMUX as a Buy, 1 (50%) are recommending IMUX as a Hold, 0 (0%) are recommending IMUX as a Sell, and 0 (0%) are recommending IMUX as a Strong Sell.

If you're new to stock investing, here's how to buy Immunic stock.

What is IMUX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year IMUX price target, the average IMUX price target is $5.00, with the highest IMUX stock price forecast at $5.00 and the lowest IMUX stock price forecast at $5.00.

On average, Wall Street analysts predict that Immunic's share price could reach $5.00 by Jan 31, 2024. The average Immunic stock price prediction forecasts a potential upside of 237.84% from the current IMUX share price of $1.48.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.